Profilo
Attualmente Raffaele Sabia ricopre la posizione di SVP-Farmaceutical Research & Development in Recordati SpA. Sabia ha precedentemente ricoperto la posizione di Clinical Research Manager in Schwarz Pharma SpA, Head-Cardio Metabolic Franchise in Elanco Italia SpA e Manager in AstraZeneca SpA.
Ultime notizie su Raffaele Sabia
Posizioni attive di Raffaele Sabia
Società | Posizione | Inizio |
---|---|---|
RECORDATI | Direttore Tecnico/Scientifico/R&S | 01/07/2017 |
Precedenti posizioni note di Raffaele Sabia
Società | Posizione | Fine |
---|---|---|
Schwarz Pharma SpA | Corporate Officer/Principal | 01/01/1997 |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Corporate Officer/Principal | - |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RECORDATI | Health Technology |
Aziende private | 3 |
---|---|
Schwarz Pharma SpA | |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Health Technology |
- Borsa valori
- Insiders
- Raffaele Sabia